Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dal Pan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Behavioural Neurology|February 4, 2014
Clock-drawing in neurological disordersG Dal Pan, Y Stern, M Sano, et al.
Clinical Pharmacology and Therapeutics|December 16, 2015
The FDA's sentinel initiative--A comprehensive approach to medical product surveillanceR Ball, M Robb, S A Anderson, et al.
International Journal of Peptide and Protein Research|November 1, 1983
Role of the carboxamide groups of the asparagine and glycinamide residues of oxytocin. Syntheses and biological properties of [5-beta-cyanoalanine] oxytocin and [9-alpha-aminoacetonitrile] oxytocinU Roy, D Gazis, G Dal Pan, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugsJ Bohn, C Kortepeter, M Muñoz, et al.
Clinical Pharmacology and Therapeutics|June 7, 2013
The future of population-based postmarket drug risk assessment: a regulator's perspectiveT A Hammad, G A Neyarapally, S Iyasu, et al.
Clinical Pharmacology and Therapeutics|March 2, 2012
Drug-induced PML: a global agenda for a global challengeM Vinhas de Souza, B Keller-Stanislawski, K Blake, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Behavioural Neurology|February 4, 2014
Clock-drawing in neurological disordersG Dal Pan, Y Stern, M Sano, et al.
Clinical Pharmacology and Therapeutics|December 16, 2015
The FDA's sentinel initiative--A comprehensive approach to medical product surveillanceR Ball, M Robb, S A Anderson, et al.
International Journal of Peptide and Protein Research|November 1, 1983
Role of the carboxamide groups of the asparagine and glycinamide residues of oxytocin. Syntheses and biological properties of [5-beta-cyanoalanine] oxytocin and [9-alpha-aminoacetonitrile] oxytocinU Roy, D Gazis, G Dal Pan, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugsJ Bohn, C Kortepeter, M Muñoz, et al.
Clinical Pharmacology and Therapeutics|June 7, 2013
The future of population-based postmarket drug risk assessment: a regulator's perspectiveT A Hammad, G A Neyarapally, S Iyasu, et al.
Clinical Pharmacology and Therapeutics|March 2, 2012
Drug-induced PML: a global agenda for a global challengeM Vinhas de Souza, B Keller-Stanislawski, K Blake, et al.
Pageof 1